Search

Patricia Ann Duffy

Examiner (ID: 7333)

Most Active Art Unit
1645
Art Unit(s)
1806, 1648, 1802, 1645, 1818
Total Applications
1671
Issued Applications
766
Pending Applications
244
Abandoned Applications
672

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5508518 [patent_doc_number] => 20090081725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Compositions of pamps and Listeria monocytogenes and methods of use' [patent_app_type] => utility [patent_app_number] => 11/498926 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 18475 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081725.pdf [firstpage_image] =>[orig_patent_app_number] => 11498926 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/498926
Compositions of pamps and Listeria monocytogenes and methods of use Aug 2, 2006 Abandoned
Array ( [id] => 5050902 [patent_doc_number] => 20070031447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides' [patent_app_type] => utility [patent_app_number] => 11/494755 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12898 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031447.pdf [firstpage_image] =>[orig_patent_app_number] => 11494755 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/494755
Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides Jul 26, 2006 Abandoned
Array ( [id] => 5557785 [patent_doc_number] => 20090269362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Method for Controlling Immunodominance' [patent_app_type] => utility [patent_app_number] => 11/996907 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8519 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269362.pdf [firstpage_image] =>[orig_patent_app_number] => 11996907 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996907
Method for Controlling Immunodominance Jul 24, 2006 Abandoned
Array ( [id] => 5302896 [patent_doc_number] => 20090297548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING ANTHRAX SPORE-ASSOCIATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/996160 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 37590 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297548.pdf [firstpage_image] =>[orig_patent_app_number] => 11996160 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996160
IMMUNOGENIC COMPOSITIONS COMPRISING ANTHRAX SPORE-ASSOCIATED PROTEINS Jul 18, 2006 Abandoned
Array ( [id] => 5342752 [patent_doc_number] => 20090181402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD' [patent_app_type] => utility [patent_app_number] => 11/995523 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13672 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181402.pdf [firstpage_image] =>[orig_patent_app_number] => 11995523 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995523
COMPOSITIONS AND METHODS FOR COUPLING A PLURALITY OF COMPOUNDS TO A SCAFFOLD Jul 13, 2006 Abandoned
Array ( [id] => 5538733 [patent_doc_number] => 20090220538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => ' VACCINE FOR STAPHYLOCOCCAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/067458 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6136 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220538.pdf [firstpage_image] =>[orig_patent_app_number] => 12067458 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067458
VACCINE FOR STAPHYLOCOCCAL INFECTIONS Jul 12, 2006 Abandoned
Array ( [id] => 5835343 [patent_doc_number] => 20060247174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Use of a peptide' [patent_app_type] => utility [patent_app_number] => 11/485692 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4099 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247174.pdf [firstpage_image] =>[orig_patent_app_number] => 11485692 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/485692
Use of a peptide Jul 12, 2006 Abandoned
Array ( [id] => 5242127 [patent_doc_number] => 20070020620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Compositions and methods for coupling a plurality of compounds to a scaffold' [patent_app_type] => utility [patent_app_number] => 11/486646 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13655 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020620.pdf [firstpage_image] =>[orig_patent_app_number] => 11486646 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/486646
Compositions and methods for coupling a plurality of compounds to a scaffold Jul 12, 2006 Abandoned
Array ( [id] => 5515377 [patent_doc_number] => 20090215684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Use of BPI Protein for Treatment of Diseases' [patent_app_type] => utility [patent_app_number] => 11/995098 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9955 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215684.pdf [firstpage_image] =>[orig_patent_app_number] => 11995098 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/995098
Use of BPI Protein for Treatment of Diseases Jul 6, 2006 Abandoned
Array ( [id] => 4675689 [patent_doc_number] => 20080213318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Malaria MSP-1 C-terminal enhanced subunit vaccine' [patent_app_type] => utility [patent_app_number] => 11/481709 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18530 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213318.pdf [firstpage_image] =>[orig_patent_app_number] => 11481709 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/481709
Malaria MSP-1 C-terminal enhanced subunit vaccine Jul 2, 2006 Abandoned
Array ( [id] => 5835340 [patent_doc_number] => 20060247171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Use of a peptide' [patent_app_type] => utility [patent_app_number] => 11/478107 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4095 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247171.pdf [firstpage_image] =>[orig_patent_app_number] => 11478107 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/478107
Use of a peptide Jun 28, 2006 Abandoned
Array ( [id] => 5270979 [patent_doc_number] => 20090074755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Use of panton-valentine leukocidin for treating and preventing staphylococcus infections' [patent_app_type] => utility [patent_app_number] => 11/451608 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16608 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074755.pdf [firstpage_image] =>[orig_patent_app_number] => 11451608 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/451608
Use of panton-valentine leukocidin for treating and preventing staphylococcus infections Jun 12, 2006 Abandoned
Array ( [id] => 5270936 [patent_doc_number] => 20090074712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Methods for Treatment and Prevention of Infection' [patent_app_type] => utility [patent_app_number] => 11/914776 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8923 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074712.pdf [firstpage_image] =>[orig_patent_app_number] => 11914776 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/914776
Methods for Treatment and Prevention of Infection May 18, 2006 Abandoned
Array ( [id] => 5391223 [patent_doc_number] => 20090208536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis' [patent_app_type] => utility [patent_app_number] => 11/920521 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2719 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208536.pdf [firstpage_image] =>[orig_patent_app_number] => 11920521 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920521
Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis May 2, 2006 Abandoned
Array ( [id] => 5368793 [patent_doc_number] => 20090306352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Basic Protein Purification Tags from Thermophilic Bacteria' [patent_app_type] => utility [patent_app_number] => 11/911563 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12941 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306352.pdf [firstpage_image] =>[orig_patent_app_number] => 11911563 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911563
Basic protein purification tags from thermophilic bacteria Apr 9, 2006 Issued
Array ( [id] => 6000708 [patent_doc_number] => 20110117104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'MONOCLONAL ANTIBODY SPECIFIC TO ANTHRAX TOXIN' [patent_app_type] => utility [patent_app_number] => 11/908249 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11752 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117104.pdf [firstpage_image] =>[orig_patent_app_number] => 11908249 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908249
Monoclonal antibody specific to anthrax toxin Mar 9, 2006 Issued
Array ( [id] => 5415775 [patent_doc_number] => 20090041662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method' [patent_app_type] => utility [patent_app_number] => 11/884876 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5912 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041662.pdf [firstpage_image] =>[orig_patent_app_number] => 11884876 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884876
Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method Feb 21, 2006 Abandoned
Array ( [id] => 557347 [patent_doc_number] => 07468427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-23 [patent_title] => 'Antibodies to PRO1275 polypeptide' [patent_app_type] => utility [patent_app_number] => 11/341175 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41789 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468427.pdf [firstpage_image] =>[orig_patent_app_number] => 11341175 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/341175
Antibodies to PRO1275 polypeptide Jan 26, 2006 Issued
Array ( [id] => 4663123 [patent_doc_number] => 20080254030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Use of Baff to Treat Th2-Mediated Conditions' [patent_app_type] => utility [patent_app_number] => 11/814959 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6468 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254030.pdf [firstpage_image] =>[orig_patent_app_number] => 11814959 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814959
Use of Baff to Treat Th2-Mediated Conditions Jan 26, 2006 Abandoned
Array ( [id] => 5618985 [patent_doc_number] => 20060188518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Glycoconjugate vaccines for use in immune-compromised populations' [patent_app_type] => utility [patent_app_number] => 11/338900 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188518.pdf [firstpage_image] =>[orig_patent_app_number] => 11338900 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/338900
Glycoconjugate vaccines for use in immune-compromised populations Jan 24, 2006 Issued
Menu